nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A1—Dacarbazine—muscle cancer	0.168	0.226	CbGbCtD
Riluzole—ABCG2—Dactinomycin—muscle cancer	0.157	0.212	CbGbCtD
Riluzole—ABCG2—Vincristine—muscle cancer	0.0969	0.131	CbGbCtD
Riluzole—ABCG2—Etoposide—muscle cancer	0.0888	0.12	CbGbCtD
Riluzole—CYP1A2—Dacarbazine—muscle cancer	0.0748	0.101	CbGbCtD
Riluzole—ABCG2—Doxorubicin—muscle cancer	0.0606	0.0817	CbGbCtD
Riluzole—ABCG2—Methotrexate—muscle cancer	0.0587	0.0791	CbGbCtD
Riluzole—CYP1A2—Etoposide—muscle cancer	0.0366	0.0494	CbGbCtD
Riluzole—SLC7A11—forelimb zeugopod—muscle cancer	0.0348	0.602	CbGeAlD
Riluzole—SLC7A11—smooth muscle tissue—muscle cancer	0.00352	0.061	CbGeAlD
Riluzole—SLC7A11—renal system—muscle cancer	0.00339	0.0587	CbGeAlD
Riluzole—SLC7A11—head—muscle cancer	0.00227	0.0393	CbGeAlD
Riluzole—SLC7A11—testis—muscle cancer	0.00219	0.0379	CbGeAlD
Riluzole—SCN5A—cardiac atrium—muscle cancer	0.00183	0.0316	CbGeAlD
Riluzole—SCN5A—vagina—muscle cancer	0.00148	0.0256	CbGeAlD
Riluzole—SCN5A—head—muscle cancer	0.00137	0.0236	CbGeAlD
Riluzole—CYP1A2—renal system—muscle cancer	0.00107	0.0186	CbGeAlD
Riluzole—CYP1A1—renal system—muscle cancer	0.00106	0.0184	CbGeAlD
Riluzole—CYP1A1—cardiac atrium—muscle cancer	0.000949	0.0164	CbGeAlD
Riluzole—ABCG2—bone marrow—muscle cancer	0.000844	0.0146	CbGeAlD
Riluzole—ABCG2—vagina—muscle cancer	0.000809	0.014	CbGeAlD
Riluzole—CYP1A1—vagina—muscle cancer	0.000768	0.0133	CbGeAlD
Riluzole—ABCG2—testis—muscle cancer	0.000722	0.0125	CbGeAlD
Riluzole—CYP1A1—head—muscle cancer	0.000709	0.0123	CbGeAlD
Riluzole—Cardiac arrest—Doxorubicin—muscle cancer	0.000226	0.00112	CcSEcCtD
Riluzole—Pancytopenia—Methotrexate—muscle cancer	0.000225	0.00112	CcSEcCtD
Riluzole—Anaphylactic shock—Etoposide—muscle cancer	0.000225	0.00112	CcSEcCtD
Riluzole—Mood swings—Doxorubicin—muscle cancer	0.000225	0.00112	CcSEcCtD
Riluzole—Infection—Etoposide—muscle cancer	0.000223	0.00111	CcSEcCtD
Riluzole—Ataxia—Doxorubicin—muscle cancer	0.000223	0.00111	CcSEcCtD
Riluzole—Asthenia—Dactinomycin—muscle cancer	0.000223	0.00111	CcSEcCtD
Riluzole—Dysuria—Methotrexate—muscle cancer	0.000221	0.0011	CcSEcCtD
Riluzole—Neutropenia—Methotrexate—muscle cancer	0.000221	0.0011	CcSEcCtD
Riluzole—Dehydration—Doxorubicin—muscle cancer	0.000221	0.0011	CcSEcCtD
Riluzole—Thrombocytopenia—Etoposide—muscle cancer	0.00022	0.0011	CcSEcCtD
Riluzole—Tachycardia—Etoposide—muscle cancer	0.000219	0.00109	CcSEcCtD
Riluzole—Body temperature increased—Vincristine—muscle cancer	0.000219	0.00109	CcSEcCtD
Riluzole—Abdominal pain—Vincristine—muscle cancer	0.000219	0.00109	CcSEcCtD
Riluzole—Liver function test abnormal—Doxorubicin—muscle cancer	0.000219	0.00109	CcSEcCtD
Riluzole—Skin disorder—Etoposide—muscle cancer	0.000218	0.00109	CcSEcCtD
Riluzole—Erectile dysfunction—Methotrexate—muscle cancer	0.000218	0.00109	CcSEcCtD
Riluzole—Hyperhidrosis—Etoposide—muscle cancer	0.000217	0.00108	CcSEcCtD
Riluzole—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000217	0.00108	CcSEcCtD
Riluzole—Photosensitivity reaction—Methotrexate—muscle cancer	0.000216	0.00108	CcSEcCtD
Riluzole—Hypokalaemia—Doxorubicin—muscle cancer	0.000216	0.00107	CcSEcCtD
Riluzole—Breast disorder—Doxorubicin—muscle cancer	0.000214	0.00107	CcSEcCtD
Riluzole—Anorexia—Etoposide—muscle cancer	0.000214	0.00107	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000214	0.00106	CcSEcCtD
Riluzole—Diarrhoea—Dactinomycin—muscle cancer	0.000213	0.00106	CcSEcCtD
Riluzole—Pneumonia—Methotrexate—muscle cancer	0.000212	0.00106	CcSEcCtD
Riluzole—Infestation—Methotrexate—muscle cancer	0.000211	0.00105	CcSEcCtD
Riluzole—Infestation NOS—Methotrexate—muscle cancer	0.000211	0.00105	CcSEcCtD
Riluzole—Depression—Methotrexate—muscle cancer	0.000211	0.00105	CcSEcCtD
Riluzole—Hypotension—Etoposide—muscle cancer	0.00021	0.00105	CcSEcCtD
Riluzole—Gastritis—Doxorubicin—muscle cancer	0.00021	0.00104	CcSEcCtD
Riluzole—Muscular weakness—Doxorubicin—muscle cancer	0.000209	0.00104	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000209	0.00104	CcSEcCtD
Riluzole—Abdominal distension—Doxorubicin—muscle cancer	0.000206	0.00103	CcSEcCtD
Riluzole—Stomatitis—Methotrexate—muscle cancer	0.000206	0.00102	CcSEcCtD
Riluzole—Influenza—Doxorubicin—muscle cancer	0.000205	0.00102	CcSEcCtD
Riluzole—Asthma—Doxorubicin—muscle cancer	0.000205	0.00102	CcSEcCtD
Riluzole—Dysphagia—Doxorubicin—muscle cancer	0.000205	0.00102	CcSEcCtD
Riluzole—Hypersensitivity—Vincristine—muscle cancer	0.000204	0.00102	CcSEcCtD
Riluzole—Sweating—Methotrexate—muscle cancer	0.000202	0.00101	CcSEcCtD
Riluzole—Paraesthesia—Etoposide—muscle cancer	0.000202	0.001	CcSEcCtD
Riluzole—Haematuria—Methotrexate—muscle cancer	0.000201	0.001	CcSEcCtD
Riluzole—Pancreatitis—Doxorubicin—muscle cancer	0.000201	0.001	CcSEcCtD
Riluzole—Dyspnoea—Etoposide—muscle cancer	0.0002	0.000998	CcSEcCtD
Riluzole—Somnolence—Etoposide—muscle cancer	0.0002	0.000995	CcSEcCtD
Riluzole—Angina pectoris—Doxorubicin—muscle cancer	0.0002	0.000994	CcSEcCtD
Riluzole—Hepatobiliary disease—Methotrexate—muscle cancer	0.0002	0.000994	CcSEcCtD
Riluzole—Epistaxis—Methotrexate—muscle cancer	0.000199	0.000991	CcSEcCtD
Riluzole—Asthenia—Vincristine—muscle cancer	0.000199	0.000991	CcSEcCtD
Riluzole—Vomiting—Dactinomycin—muscle cancer	0.000197	0.000983	CcSEcCtD
Riluzole—Bronchitis—Doxorubicin—muscle cancer	0.000197	0.000981	CcSEcCtD
Riluzole—Agranulocytosis—Methotrexate—muscle cancer	0.000197	0.000981	CcSEcCtD
Riluzole—Rash—Dactinomycin—muscle cancer	0.000196	0.000975	CcSEcCtD
Riluzole—Decreased appetite—Etoposide—muscle cancer	0.000195	0.000973	CcSEcCtD
Riluzole—Pancytopenia—Doxorubicin—muscle cancer	0.000195	0.000969	CcSEcCtD
Riluzole—Gastrointestinal disorder—Etoposide—muscle cancer	0.000194	0.000966	CcSEcCtD
Riluzole—Fatigue—Etoposide—muscle cancer	0.000194	0.000965	CcSEcCtD
Riluzole—Pain—Etoposide—muscle cancer	0.000192	0.000957	CcSEcCtD
Riluzole—Constipation—Etoposide—muscle cancer	0.000192	0.000957	CcSEcCtD
Riluzole—Neutropenia—Doxorubicin—muscle cancer	0.000192	0.000954	CcSEcCtD
Riluzole—Dysuria—Doxorubicin—muscle cancer	0.000192	0.000954	CcSEcCtD
Riluzole—Haemoglobin—Methotrexate—muscle cancer	0.00019	0.000948	CcSEcCtD
Riluzole—Diarrhoea—Vincristine—muscle cancer	0.00019	0.000945	CcSEcCtD
Riluzole—Haemorrhage—Methotrexate—muscle cancer	0.00019	0.000943	CcSEcCtD
Riluzole—Hepatitis—Methotrexate—muscle cancer	0.00019	0.000943	CcSEcCtD
Riluzole—Pollakiuria—Doxorubicin—muscle cancer	0.000189	0.000943	CcSEcCtD
Riluzole—Pharyngitis—Methotrexate—muscle cancer	0.000188	0.000936	CcSEcCtD
Riluzole—Urinary tract disorder—Methotrexate—muscle cancer	0.000187	0.000932	CcSEcCtD
Riluzole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000187	0.000931	CcSEcCtD
Riluzole—Weight increased—Doxorubicin—muscle cancer	0.000187	0.000929	CcSEcCtD
Riluzole—Urethral disorder—Methotrexate—muscle cancer	0.000186	0.000925	CcSEcCtD
Riluzole—Weight decreased—Doxorubicin—muscle cancer	0.000185	0.000923	CcSEcCtD
Riluzole—Feeling abnormal—Etoposide—muscle cancer	0.000185	0.000922	CcSEcCtD
Riluzole—Nausea—Dactinomycin—muscle cancer	0.000184	0.000918	CcSEcCtD
Riluzole—Pneumonia—Doxorubicin—muscle cancer	0.000184	0.000915	CcSEcCtD
Riluzole—Gastrointestinal pain—Etoposide—muscle cancer	0.000184	0.000915	CcSEcCtD
Riluzole—Dizziness—Vincristine—muscle cancer	0.000183	0.000913	CcSEcCtD
Riluzole—Infestation NOS—Doxorubicin—muscle cancer	0.000183	0.00091	CcSEcCtD
Riluzole—Infestation—Doxorubicin—muscle cancer	0.000183	0.00091	CcSEcCtD
Riluzole—Erythema multiforme—Methotrexate—muscle cancer	0.000179	0.000892	CcSEcCtD
Riluzole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000179	0.000892	CcSEcCtD
Riluzole—Urticaria—Etoposide—muscle cancer	0.000179	0.000889	CcSEcCtD
Riluzole—Jaundice—Doxorubicin—muscle cancer	0.000178	0.000887	CcSEcCtD
Riluzole—Stomatitis—Doxorubicin—muscle cancer	0.000178	0.000887	CcSEcCtD
Riluzole—Body temperature increased—Etoposide—muscle cancer	0.000178	0.000885	CcSEcCtD
Riluzole—Abdominal pain—Etoposide—muscle cancer	0.000178	0.000885	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—muscle cancer	0.000178	0.000884	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—muscle cancer	0.000177	0.000882	CcSEcCtD
Riluzole—Vomiting—Vincristine—muscle cancer	0.000176	0.000878	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—muscle cancer	0.000176	0.000875	CcSEcCtD
Riluzole—Sweating—Doxorubicin—muscle cancer	0.000175	0.000872	CcSEcCtD
Riluzole—Rash—Vincristine—muscle cancer	0.000175	0.000871	CcSEcCtD
Riluzole—Dermatitis—Vincristine—muscle cancer	0.000175	0.00087	CcSEcCtD
Riluzole—Haematuria—Doxorubicin—muscle cancer	0.000174	0.000868	CcSEcCtD
Riluzole—Headache—Vincristine—muscle cancer	0.000174	0.000865	CcSEcCtD
Riluzole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000173	0.000861	CcSEcCtD
Riluzole—Epistaxis—Doxorubicin—muscle cancer	0.000172	0.000858	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—muscle cancer	0.000172	0.000856	CcSEcCtD
Riluzole—Sinusitis—Doxorubicin—muscle cancer	0.000171	0.000854	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—muscle cancer	0.000171	0.000852	CcSEcCtD
Riluzole—Mediastinal disorder—Methotrexate—muscle cancer	0.000171	0.00085	CcSEcCtD
Riluzole—Agranulocytosis—Doxorubicin—muscle cancer	0.000171	0.000849	CcSEcCtD
Riluzole—Chills—Methotrexate—muscle cancer	0.00017	0.000846	CcSEcCtD
Riluzole—Alopecia—Methotrexate—muscle cancer	0.000167	0.000834	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—muscle cancer	0.000167	0.000832	CcSEcCtD
Riluzole—Mental disorder—Methotrexate—muscle cancer	0.000166	0.000826	CcSEcCtD
Riluzole—Hypersensitivity—Etoposide—muscle cancer	0.000166	0.000824	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—muscle cancer	0.000165	0.000821	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—muscle cancer	0.000165	0.000821	CcSEcCtD
Riluzole—Nausea—Vincristine—muscle cancer	0.000165	0.00082	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—muscle cancer	0.000165	0.000819	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—muscle cancer	0.000164	0.000817	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—muscle cancer	0.000164	0.000817	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—muscle cancer	0.000163	0.000813	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—muscle cancer	0.000163	0.000811	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—muscle cancer	0.000162	0.000807	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—muscle cancer	0.000162	0.000805	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—muscle cancer	0.000162	0.000804	CcSEcCtD
Riluzole—Asthenia—Etoposide—muscle cancer	0.000161	0.000803	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—muscle cancer	0.000161	0.000803	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—muscle cancer	0.000161	0.000801	CcSEcCtD
Riluzole—Back pain—Methotrexate—muscle cancer	0.00016	0.000794	CcSEcCtD
Riluzole—Pruritus—Etoposide—muscle cancer	0.000159	0.000792	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—muscle cancer	0.000155	0.000772	CcSEcCtD
Riluzole—Diarrhoea—Etoposide—muscle cancer	0.000154	0.000766	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—muscle cancer	0.000153	0.000763	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—muscle cancer	0.000153	0.000762	CcSEcCtD
Riluzole—Anaemia—Methotrexate—muscle cancer	0.000152	0.000759	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—muscle cancer	0.000152	0.000758	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—muscle cancer	0.000149	0.000741	CcSEcCtD
Riluzole—Malaise—Methotrexate—muscle cancer	0.000149	0.000741	CcSEcCtD
Riluzole—Dizziness—Etoposide—muscle cancer	0.000149	0.00074	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—muscle cancer	0.000148	0.000738	CcSEcCtD
Riluzole—Vertigo—Methotrexate—muscle cancer	0.000148	0.000738	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000148	0.000736	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—muscle cancer	0.000148	0.000735	CcSEcCtD
Riluzole—Chills—Doxorubicin—muscle cancer	0.000147	0.000733	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—muscle cancer	0.000147	0.00073	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—muscle cancer	0.000145	0.000722	CcSEcCtD
Riluzole—Cough—Methotrexate—muscle cancer	0.000144	0.000717	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—muscle cancer	0.000144	0.000716	CcSEcCtD
Riluzole—Convulsion—Methotrexate—muscle cancer	0.000143	0.000711	CcSEcCtD
Riluzole—Vomiting—Etoposide—muscle cancer	0.000143	0.000711	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—muscle cancer	0.000143	0.000711	CcSEcCtD
Riluzole—Rash—Etoposide—muscle cancer	0.000142	0.000705	CcSEcCtD
Riluzole—Dermatitis—Etoposide—muscle cancer	0.000142	0.000705	CcSEcCtD
Riluzole—Headache—Etoposide—muscle cancer	0.000141	0.000701	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—muscle cancer	0.000141	0.000701	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—muscle cancer	0.00014	0.000699	CcSEcCtD
Riluzole—Chest pain—Methotrexate—muscle cancer	0.00014	0.000699	CcSEcCtD
Riluzole—Myalgia—Methotrexate—muscle cancer	0.00014	0.000699	CcSEcCtD
Riluzole—Tension—Doxorubicin—muscle cancer	0.00014	0.000698	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—muscle cancer	0.00014	0.000696	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000139	0.000694	CcSEcCtD
Riluzole—Discomfort—Methotrexate—muscle cancer	0.000139	0.000691	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—muscle cancer	0.000139	0.000691	CcSEcCtD
Riluzole—Back pain—Doxorubicin—muscle cancer	0.000138	0.000688	CcSEcCtD
Riluzole—Muscle spasms—Doxorubicin—muscle cancer	0.000137	0.000684	CcSEcCtD
Riluzole—Confusional state—Methotrexate—muscle cancer	0.000136	0.000676	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—muscle cancer	0.000135	0.00067	CcSEcCtD
Riluzole—Infection—Methotrexate—muscle cancer	0.000134	0.000666	CcSEcCtD
Riluzole—Nausea—Etoposide—muscle cancer	0.000134	0.000665	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—muscle cancer	0.000133	0.00066	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—muscle cancer	0.000132	0.000657	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—muscle cancer	0.000132	0.000657	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—muscle cancer	0.000132	0.000656	CcSEcCtD
Riluzole—Agitation—Doxorubicin—muscle cancer	0.000131	0.000653	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—muscle cancer	0.000131	0.000651	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—muscle cancer	0.00013	0.000648	CcSEcCtD
Riluzole—Malaise—Doxorubicin—muscle cancer	0.000129	0.000641	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—muscle cancer	0.000128	0.000639	CcSEcCtD
Riluzole—Anorexia—Methotrexate—muscle cancer	0.000128	0.000639	CcSEcCtD
Riluzole—Syncope—Doxorubicin—muscle cancer	0.000128	0.000638	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—muscle cancer	0.000128	0.000636	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—muscle cancer	0.000126	0.000628	CcSEcCtD
Riluzole—Hypotension—Methotrexate—muscle cancer	0.000126	0.000626	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—muscle cancer	0.000126	0.000625	CcSEcCtD
Riluzole—Cough—Doxorubicin—muscle cancer	0.000125	0.00062	CcSEcCtD
Riluzole—Convulsion—Doxorubicin—muscle cancer	0.000124	0.000616	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—muscle cancer	0.000123	0.000614	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000123	0.000611	CcSEcCtD
Riluzole—Insomnia—Methotrexate—muscle cancer	0.000122	0.000606	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—muscle cancer	0.000122	0.000605	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—muscle cancer	0.000122	0.000605	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—muscle cancer	0.000122	0.000605	CcSEcCtD
Riluzole—Anxiety—Doxorubicin—muscle cancer	0.000121	0.000603	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—muscle cancer	0.000121	0.000602	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000121	0.000601	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—muscle cancer	0.00012	0.000598	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—muscle cancer	0.00012	0.000598	CcSEcCtD
Riluzole—Somnolence—Methotrexate—muscle cancer	0.00012	0.000596	CcSEcCtD
Riluzole—Dry mouth—Doxorubicin—muscle cancer	0.000119	0.000592	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—muscle cancer	0.000119	0.00059	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—muscle cancer	0.000118	0.000585	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—muscle cancer	0.000117	0.000583	CcSEcCtD
Riluzole—Oedema—Doxorubicin—muscle cancer	0.000117	0.00058	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000117	0.00058	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000116	0.000579	CcSEcCtD
Riluzole—Fatigue—Methotrexate—muscle cancer	0.000116	0.000578	CcSEcCtD
Riluzole—Infection—Doxorubicin—muscle cancer	0.000116	0.000577	CcSEcCtD
Riluzole—Pain—Methotrexate—muscle cancer	0.000115	0.000573	CcSEcCtD
Riluzole—Shock—Doxorubicin—muscle cancer	0.000115	0.000571	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—muscle cancer	0.000114	0.000569	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000114	0.000568	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—muscle cancer	0.000114	0.000566	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—muscle cancer	0.000113	0.000564	CcSEcCtD
Riluzole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000113	0.000561	CcSEcCtD
Riluzole—Anorexia—Doxorubicin—muscle cancer	0.000111	0.000553	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—muscle cancer	0.000111	0.000552	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—muscle cancer	0.00011	0.000548	CcSEcCtD
Riluzole—Hypotension—Doxorubicin—muscle cancer	0.000109	0.000542	CcSEcCtD
Riluzole—Urticaria—Methotrexate—muscle cancer	0.000107	0.000532	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—muscle cancer	0.000106	0.00053	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—muscle cancer	0.000106	0.00053	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000106	0.000529	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—muscle cancer	0.000105	0.000525	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—muscle cancer	0.000105	0.000521	CcSEcCtD
Riluzole—Dyspnoea—Doxorubicin—muscle cancer	0.000104	0.000517	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—muscle cancer	0.000104	0.000516	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—muscle cancer	0.000103	0.000511	CcSEcCtD
Riluzole—Decreased appetite—Doxorubicin—muscle cancer	0.000101	0.000504	CcSEcCtD
Riluzole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000101	0.000501	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—muscle cancer	0.000101	0.0005	CcSEcCtD
Riluzole—Constipation—Doxorubicin—muscle cancer	9.97e-05	0.000496	CcSEcCtD
Riluzole—Pain—Doxorubicin—muscle cancer	9.97e-05	0.000496	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—muscle cancer	9.92e-05	0.000494	CcSEcCtD
Riluzole—Asthenia—Methotrexate—muscle cancer	9.66e-05	0.000481	CcSEcCtD
Riluzole—Feeling abnormal—Doxorubicin—muscle cancer	9.61e-05	0.000478	CcSEcCtD
Riluzole—Gastrointestinal pain—Doxorubicin—muscle cancer	9.53e-05	0.000475	CcSEcCtD
Riluzole—Pruritus—Methotrexate—muscle cancer	9.53e-05	0.000474	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—muscle cancer	9.26e-05	0.000461	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—muscle cancer	9.22e-05	0.000459	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—muscle cancer	9.22e-05	0.000459	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—muscle cancer	9.21e-05	0.000459	CcSEcCtD
Riluzole—Dizziness—Methotrexate—muscle cancer	8.9e-05	0.000443	CcSEcCtD
Riluzole—Hypersensitivity—Doxorubicin—muscle cancer	8.59e-05	0.000428	CcSEcCtD
Riluzole—Vomiting—Methotrexate—muscle cancer	8.56e-05	0.000426	CcSEcCtD
Riluzole—Rash—Methotrexate—muscle cancer	8.49e-05	0.000423	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—muscle cancer	8.48e-05	0.000422	CcSEcCtD
Riluzole—Headache—Methotrexate—muscle cancer	8.43e-05	0.00042	CcSEcCtD
Riluzole—Asthenia—Doxorubicin—muscle cancer	8.36e-05	0.000416	CcSEcCtD
Riluzole—Pruritus—Doxorubicin—muscle cancer	8.25e-05	0.000411	CcSEcCtD
Riluzole—Nausea—Methotrexate—muscle cancer	8e-05	0.000398	CcSEcCtD
Riluzole—Diarrhoea—Doxorubicin—muscle cancer	7.98e-05	0.000397	CcSEcCtD
Riluzole—Dizziness—Doxorubicin—muscle cancer	7.71e-05	0.000384	CcSEcCtD
Riluzole—Vomiting—Doxorubicin—muscle cancer	7.41e-05	0.000369	CcSEcCtD
Riluzole—Rash—Doxorubicin—muscle cancer	7.35e-05	0.000366	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—muscle cancer	7.34e-05	0.000366	CcSEcCtD
Riluzole—Headache—Doxorubicin—muscle cancer	7.3e-05	0.000364	CcSEcCtD
Riluzole—Nausea—Doxorubicin—muscle cancer	6.93e-05	0.000345	CcSEcCtD
